Dr. Peyman Benharash, MD

Dr. Benharash practices at Peter Morton UCLA Medical Building in Los Angeles, California.

Dr. Benharash's NPI, 1003000639, was assigned on August 27, 2007. Dr. Benharash graduated from David Geffen School of Medicine at UCLA in 2002. Dr. Benharash's California license number on file is A85379.

Dr. Benharash's primary practice is Peter Morton UCLA Medical Building, at 200 Medical Plz, Los Angeles, CA 90024 in Los Angeles County. The practice phone is (310) 794-9206.

Dr. Benharash's primary practice is Peter Morton UCLA Medical Building in Los Angeles, California. Dr. Benharash is also affiliated with Ronald Reagan UCLA Medical Center. The medical group on file is UCLA Medical Group. Dmand AI also links Dr. Benharash to 2 more hospitals, 2 group practices and clinics, 1 home health agency and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Benharash practices, 6 sites in all. Vendor and product names are available with a free account.

Surgery is Dr. Benharash's primary specialty in the NPI Registry, under taxonomy code 208600000X. Dr. Benharash is board certified in thoracic and cardiac surgery by the American Board of Thoracic Surgery. Dr. Benharash has a license on file in California.

Dmand AI lists heart bypass surgery and heart valve surgery among the conditions Dr. Benharash treats.

CMS data shows 128 Medicare services from Dr. Benharash across 7 procedure codes in 2024, for 106 Medicare patients. Medicare paid $47,321 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 106 Medicare patients who saw Dr. Benharash in 2024. The largest group is 65 to 74, with 44 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 22% are also on Medicaid. Their average risk score is 1.85, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Benharash's median patient age at 65, with 28% women.

In 2024, Dr. Benharash wrote 14 Medicare Part D claims. 86% of them were for generic drugs. They cover 1 drug, with $143 in total drug cost.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Benharash for performance year 2024, reported as part of a group. Dr. Benharash accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 25 procedures of coronary artery bypass graft (cabg) by Dr. Benharash, more than 76% of the clinicians it reports for that procedure.

Dmand AI links 85 papers to Dr. Benharash, published from 2010 to 2025. 2025 was the busiest year, with 19. The most frequent topics are Postoperative Complications, Hospital Mortality and Length of Stay. Dr. Benharash has published most often in Surgery. Dr. Benharash's most frequent co-authors are Sohail Sareh, MD, Esteban Aguayo, MD and Vishal V. Dobaria, MD.

Dmand AI links Dr. Benharash to 10 clinical trials, 4 of them phase 2 studies. 9 are still active or recruiting. Conditions studied include Adenocarcinoma of Lung, Biliary Atresia and Low Back Pain.

CMS Open Payments shows 297 general payments to Dr. Benharash from 17 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 79% of the total. AtriCure, Inc. paid the most, $78,235.

Dr. Benharash graduated from David Geffen School of Medicine at UCLA in 2002. Dr. Benharash is a member of STS.

Dr. Benharash is in network with 15 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.